BST2 and HIV-1 infection: While all studies to date in chronic infection have used IFN-α2a, other IFN-α subtypes, as well as IFN-β, have been shown to be more potent at upregulating BST-2 and restricting HIV-1 infection (Fig. 1) (52, 63, 64).